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SUMMARY. A simple and cost-effective method by capillary zone electrophoresis (CZE) was developed
and validated for the simultaneous determination of the antituberculosis drugs isoniazid (INH), pyrazi-
namide (PYR), and rifampicin (RIF) in tablets. A 40 mmol L–1 sodium tetraborate background electrolyte
(BGE) solution (pH 9.0) was found to be suitable for separation of all the analytes. An uncoated fused-sili-
ca capillary of 64.5 cm length (effective length 56 cm) was used for chromatography separation. All ana-
lytes were completely separated within 5 min at an applied voltage of 20 kV (max. 50 μA), and detection
was performed at 269.5 nm with an UV detector. The method was validated in terms of linearity, accura-
cy, precision, and robustness. The linearities of the calibration curves for INH, PYR, and RIF were 40-120
μg/mL (r2 = 0.9994), 20-100 μg/mL (r2 = 0.9997), and 40-100 μg/mL (r2= 0.9999), respectively. The pro-
posed method was successfully applied for the simultaneous determination of the tuberculostatic drugs
RIF, INH, and PYR in tablets. Thus, the proposed CZE method is a potential alternative to the HPLC
methods described by the US Pharmacopoeia for the quality control of tuberculostatic drugs.
